Merck Global Health Innovation Fund

Total investments

99

Average round size

27M

Portfolio companies

58

Rounds per year

7.07

Lead investments

13

Follow on index

0.41

Exits

22

Areas of investment
BiotechnologySoftwareAnalyticsInformation TechnologyHealth CareHealth DiagnosticsWellnessMedical DeviceMedicalPharmaceutical

Investments analytics

Analytics

Total investments
99
Lead investments
13
Exits
22
Rounds per year
7.07
Follow on index
0.41
Investments by industry
  • Health Care (74)
  • Biotechnology (31)
  • Medical (30)
  • Information Technology (27)
  • Software (20)
  • Show 53 more
Investments by region
  • United States (89)
  • United Kingdom (3)
  • Hungary (1)
  • Denmark (1)
  • Canada (3)
  • Show 1 more
Peak activity year
2015
Number of Unicorns
2
Number of Decacorns
2

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
14
Avg. valuation at time of investment
500M
Group Appearance index
0.81
Avg. company exit year
15
Avg. multiplicator
17.84
Strategy success index
0.60

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
CargoSense 12 Jun 2024 Logistics, Analytics, Health Care, SaaS, Big Data, Cloud Computing, Internet of Things Early Stage Venture 8M United States, Virginia
PreciseDx 11 Jan 2022 Health Care Early Stage Venture 10M United States, New York, New York
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.